Alerts will be sent to your verified email
Verify Email
SANOFICONR
|
Sanofi Cons. Health
|
Concord Biotech
|
Medplus Health Servi
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
72.87 % | 19.73 % | 6.33 % |
|
5yr average Equity Multiplier
|
1.82 | 1.21 | 1.94 |
|
5yr Average Asset Turnover Ratio
|
1.48 | 0.54 | 1.75 |
|
5yr Avg Net Profit Margin
|
27.34 % | 30.4 % | 1.86 % |
|
Price to Book
|
27.86 | 5.9 | 5.42 |
|
P/E
|
44.55 | 34.49 | 48.27 |
|
5yr Avg Cash Conversion Cycle
|
-83.69 Days | 76.63 Days | 57.95 Days |
|
Inventory Days
|
47.09 Days | 79.03 Days | 80.0 Days |
|
Days Receivable
|
10.93 Days | 132.49 Days | 0.9 Days |
|
Days Payable
|
135.97 Days | 157.9 Days | 24.38 Days |
|
5yr Average Interest Coverage Ratio
|
32.14 | 195.92 | 2.1 |
|
5yr Avg ROCE
|
99.14 % | 25.76 % | 9.85 % |
|
5yr Avg Operating Profit Margin
|
38.38 % | 43.43 % | 7.22 % |
|
5 yr average Debt to Equity
|
0.0 | 0.03 | 0.06 |
|
5yr CAGR Net Profit
|
1.88 % | 9.62 % | 18.67 % |
|
5yr Average Return on Assets
|
40.56 % | 16.36 % | 3.23 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
71.27 % | 44.08 % | 40.29 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 60.74 % |
|
Change in Promoter Holding (3 Yrs)
|
10.87 % | 0.0 | -0.14 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.4 % | -1.14 % | 9.54 % |
|
Sanofi Cons. Health
|
Concord Biotech
|
Medplus Health Servi
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|